FDA Early Collaboration Guidance Offers Incentives For Formal Meetings
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers have the option of postponing agreement meetings until informal "pre-meetings" with FDA are completed, according to a revised guidance outlining early collaborations under the FDA Modernization Act of 1997.